| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,347 | 24,796 | 18,945 | 33,679 | | Cost of Revenue | 27,997 | 22,061 | 21,202 | 35,275 | | | Gross Profit | 1,349 | 2,735 | (2,258) | (1,596) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,176 | 1,562 | 1,953 | 1,715 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (827) | 1,173 | (4,211) | (3,311) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 269 | (58) | (395) | 191 | | Earnings Before Interest And Taxes | (558) | 1,115 | (4,606) | (3,120) | | Interest Expense | 358 | 392 | 456 | 417 | | Income Before Tax | (916) | 722 | (5,062) | (3,537) | | Income Tax Expense | 532 | 134 | (2,194) | (1,343) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,448) | 588 | (2,868) | (2,195) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,448) | 588 | (2,868) | (2,195) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,448) | $588 | ($2,868) | ($2,195) |
|
0.03% Nasdaq 
Income Statement
